GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **701 - 725** of **4050** in total

« First

‹ Prev

…

25

26

27

28

29

30

31

32

33

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	24	mild	G82204SH	457
IgG	Patient 2	15	mild	G82204SH	62
IgG	Patient 2	24	mild	G82204SH	66
IgM	Patient 2	15	mild	G82204SH	462
IgA	Patient 2	3	mild	G82204SH	289
IgG	Patient 2	3	mild	G82204SH	36
IgM	Patient 2	24	mild	G82204SH	553
IgM	Patient 2	3	mild	G82204SH	82
IgA	Patient 3	-180	mild	G82204SH	2176
IgA	Patient 3	11	mild	G82204SH	2095
IgG	Patient 3	-180	mild	G82204SH	874
IgM	Patient 3	-180	mild	G82204SH	6358
IgA	Patient 3	4	mild	G82204SH	2515
IgG	Patient 3	11	mild	G82204SH	858
IgG	Patient 3	4	mild	G82204SH	908
IgM	Patient 3	11	mild	G82204SH	6671
IgM	Patient 3	4	mild	G82204SH	7583
IgA	Patient 4	12	mild	G82204SH	358
IgG	Patient 4	12	mild	G82204SH	77
IgM	Patient 4	12	mild	G82204SH	159
IgA	Patient 1	10	moderate	G82096UQ	393
IgA	Patient 1	22	moderate	G82096UQ	343
IgA	Patient 1	6	moderate	G82096UQ	399
IgG	Patient 1	10	moderate	G82096UQ	27
IgG	Patient 1	22	moderate	G82096UQ	28